|
Category: pharmaceuticals / chemical synthisis
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Melting Point: | 350.00 °C. @ 760.00 mm Hg
|
| Boiling Point: | 608.77 °C. @ 760.00 mm Hg (est)
|
| Flash Point: | 612.00 °F. TCC ( 322.00 °C. ) (est)
|
| logP (o/w): | -0.240 |
| Soluble in: |
| | water, 1854 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
intravenous-dog LD50 1000 mg/kg "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes, C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973Vol. -, Pg. 77, 1973.
intraperitoneal-mouse LD50 1400 mg/kg LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Journal of Pharmacology and Experimental Therapeutics. Vol. 134, Pg. 273, 1961.
intravenous-mouse LD50 940 mg/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES Journal of Pharmacology and Experimental Therapeutics. Vol. 134, Pg. 273, 1961.
oral-mouse LD50 8000 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. Vol. 118, Pg. 467, 1959.
intraperitoneal-rat LD50 1386 mg/kg "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes, C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973Vol. -, Pg. 77, 1973.
intravenous-rat LD50 200 mg/kg Toxicology and Applied Pharmacology. Vol. 1, Pg. 333, 1959.
oral-rat LD50 10000 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 21, Pg. 775, 1979.
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | pharmaceuticals / chemical synthisis |
| Recommendation for chlorothiazide usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for chlorothiazide flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
| | 6-chloro-1,1-dioxo-4H-1lamda6,2,4-benzothiadiazine-7-sulfonamide |
| NIST Chemistry WebBook: | Search Inchi |
| Pubchem (cid): | 2720 |
| Pubchem (sid): | 134972119 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| 2H-1,2,4- | benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide | | 4H-1,2,4- | benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide | | 6- | chloro-1,1-dioxo-4H-1lamda6,2,4-benzothiadiazine-7-sulfonamide | | 6- | chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide | | 6- | chloro-4H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide | | 6- | chloro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide | | 6- | chloro-7-sulfamyl-1,2,4-benzothiadiazine 1,1-dioxide | | | chlorothiazid | | | chlorothiazidum | | | clotride | | | diurilix | | | diutrid | | | minzil | | | salisan | | | saluretil | | | warduzide | | | yadalan | | | yadulan |
Articles:
|